Sign in
Download Opera News App

STOCK INVESTMENT

TRACON Pharmaceuticals Announces $5.0 Million Registered Direct Offering

TRACON Pharmaceuticals Announces $5.0 Million Registered Direct Offering

SAN DIEGO, Dec. 29, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S.,...

Read Full Story
Company ENVASARC SAN DIEGO SEC TRACON TRACON Pharmaceuticals

Top News

MIDDLE EAST POLITICS

Lack of sanctions for crown prince shows the might of Saudi Arabia

theguardian.com
Lack of sanctions for crown prince shows the might of Saudi Arabia

MIDDLE EAST POLITICS

Lack of sanctions for crown prince shows the might of Saudi Arabia

theguardian.com

US POLITICS

Progressives push to squash Senate filibuster after minimum wage defeat

politico.com
Progressives push to squash Senate filibuster after minimum wage defeat

US POLITICS

Progressives push to squash Senate filibuster after minimum wage defeat

politico.com